Andrew Hirsch, PRESIDENT & CEO, Director at DNIB Unwind, Inc., holds 221.86K shares in C4 Therapeutics (Ticker: CCCC), holds 24.27K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Editas Medicine (Ticker: EDIT).
What is the percentage of profitable transactions made by Andrew Hirsch?
The percentage of profitable transactions made by Andrew Hirsch is ―.
What is the average return per transaction made by Andrew Hirsch?
The average return per transaction made by Andrew Hirsch is ―.
What stocks does Andrew Hirsch hold?
Andrew Hirsch holds: BINDQ, AGIO, EDIT, CCCC stocks.
What was Andrew Hirsch’s latest transaction?
Andrew Hirsch latest transaction was an Uninformative Buy of $41.98K.
What was Andrew Hirsch's most profitable transaction?
Andrew Hirsch’s most profitable transaction was an Informative Buy of CCCC stock on April 12, 2022. The return on the trade was -64.30%.
What is Andrew Hirsch's role in DNIB Unwind, Inc.?
Andrew Hirsch's role in DNIB Unwind, Inc. is PRESIDENT & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.